Suppr超能文献

全氟和多氟烷基物质暴露、妊娠体重增加与 Viva 项目产后体重变化。

Per- and Polyfluoroalkyl Substance Exposure, Gestational Weight Gain, and Postpartum Weight Changes in Project Viva.

机构信息

Population Health Sciences Program, Harvard University, Boston, Massachusetts, USA.

Department of Epidemiology, Berkeley School of Public Health, University of California, Berkeley, California, USA.

出版信息

Obesity (Silver Spring). 2020 Oct;28(10):1984-1992. doi: 10.1002/oby.22933.

Abstract

OBJECTIVE

The purpose of this study was to test the extent to which pregnancy per- and polyfluoroalkyl substance (PFAS) concentrations were associated with gestational weight gain and postpartum weight changes.

METHODS

This study was composed of 1,614 women recruited between 1999 and 2002 via the Project Viva cohort with pregnancy plasma concentrations of six PFAS, including perfluorooctanesulfonic acid, perfluorooctanoic acid (PFOA), and 2-(N-ethyl-perfluorooctane sulfonamido) acetic acid. Gestational weight gain was defined as the difference between last pregnancy weight and prepregnancy weight, 1-year postpartum weight retention as the difference between 1-year postpartum weight and prepregnancy weight, and 3-year postpartum weight change as the difference between 3-year postpartum weight and prepregnancy weight.

RESULTS

During pregnancy, women gained 0.37 kg (95% CI: 0.11-0.62) more weight per doubling of 2-(N-ethyl-perfluorooctane sulfonamido) acetic acid. At 1 year post partum, women retained 0.55 kg (95% CI: 0.07-1.04) more weight per doubling of PFOA. At 3 years post partum, women gained 0.91 kg (95% CI: 0.25-1.56) more weight per doubling in PFOA. Findings were similar after adjustment for all PFAS. Other PFAS were not associated with weight changes. Postpartum associations were stronger among women with higher prepregnancy BMI. Models were adjusted for demographics.

CONCLUSIONS

Pregnancy PFAS were associated with greater gestational weight gain, weight retention, and weight gain years after pregnancy.

摘要

目的

本研究旨在检验妊娠全氟和多氟烷基物质(PFAS)浓度与妊娠体重增加和产后体重变化的关联程度。

方法

这项研究由 1999 年至 2002 年期间通过 Project Viva 队列招募的 1614 名女性组成,她们的妊娠血浆中有六种 PFAS,包括全氟辛烷磺酸、全氟辛酸(PFOA)和 2-(N-乙基-全氟辛烷磺酰胺基)乙酸。妊娠体重增加定义为最后一次妊娠体重与妊娠前体重的差值,产后 1 年体重保留定义为产后 1 年体重与妊娠前体重的差值,产后 3 年体重变化定义为产后 3 年体重与妊娠前体重的差值。

结果

在妊娠期间,女性的体重每增加一倍 2-(N-乙基-全氟辛烷磺酰胺基)乙酸,体重就会增加 0.37 公斤(95%置信区间:0.11-0.62)。产后 1 年,女性的 PFOA 每增加一倍,体重就会增加 0.55 公斤(95%置信区间:0.07-1.04)。产后 3 年,女性的 PFOA 每增加一倍,体重就会增加 0.91 公斤(95%置信区间:0.25-1.56)。调整所有 PFAS 后,结果仍然相似。其他 PFAS 与体重变化无关。在孕前 BMI 较高的女性中,产后的关联更为强烈。模型调整了人口统计学因素。

结论

妊娠 PFAS 与妊娠体重增加、产后体重保留和产后数年体重增加有关。

相似文献

2
Pregnancy Per- and Polyfluoroalkyl Substance Concentrations and Postpartum Health in Project Viva: A Prospective Cohort.
J Clin Endocrinol Metab. 2020 Sep 1;105(9):e3415-26. doi: 10.1210/clinem/dgaa431.
4
6
Plasma concentrations of per- and polyfluoroalkyl substances in pregnancy and breastfeeding duration in Project Viva.
Sci Total Environ. 2023 Sep 15;891:164724. doi: 10.1016/j.scitotenv.2023.164724. Epub 2023 Jun 7.
9
Sociodemographic and Perinatal Predictors of Early Pregnancy Per- and Polyfluoroalkyl Substance (PFAS) Concentrations.
Environ Sci Technol. 2015 Oct 6;49(19):11849-58. doi: 10.1021/acs.est.5b02489. Epub 2015 Sep 11.
10
Postpartum Weight Retention in Primiparous Women and Weight Outcomes in Their Offspring.
J Midwifery Womens Health. 2019 Jul;64(4):427-434. doi: 10.1111/jmwh.12986. Epub 2019 Jul 12.

引用本文的文献

2
Early-pregnancy per- and polyfluoroalkyl substances and maternal post-pregnancy weight trajectory.
Obesity (Silver Spring). 2025 Apr;33(4):807-816. doi: 10.1002/oby.24250. Epub 2025 Mar 12.
5
Early Pregnancy Plasma Per- and Polyfluoroalkyl Substances (PFAS) and Maternal Midlife Adiposity.
J Clin Endocrinol Metab. 2025 May 19;110(6):e1966-e1974. doi: 10.1210/clinem/dgae542.
6
Endocrine disrupting chemicals: gestational diabetes and beyond.
Diabetol Metab Syndr. 2024 Apr 26;16(1):95. doi: 10.1186/s13098-024-01317-9.
7
Effect of Per and Poly-Fluoroalkyl Substances on Pregnancy and Child Development.
Curr Pediatr Rev. 2025;21(2):142-153. doi: 10.2174/0115733963267526231120110100.
10
Plasma concentrations of per- and polyfluoroalkyl substances in pregnancy and breastfeeding duration in Project Viva.
Sci Total Environ. 2023 Sep 15;891:164724. doi: 10.1016/j.scitotenv.2023.164724. Epub 2023 Jun 7.

本文引用的文献

2
Associations of Perfluoroalkyl and Polyfluoroalkyl Substances With Incident Diabetes and Microvascular Disease.
Diabetes Care. 2019 Sep;42(9):1824-1832. doi: 10.2337/dc18-2254. Epub 2019 Jul 11.
3
Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Adiposity.
JAMA Netw Open. 2018 Aug 3;1(4):e181493. doi: 10.1001/jamanetworkopen.2018.1493.
4
Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: A prospective study.
PLoS Med. 2018 Feb 13;15(2):e1002502. doi: 10.1371/journal.pmed.1002502. eCollection 2018 Feb.
5
Perfluoroalkyl acid levels in first-time mothers in relation to offspring weight gain and growth.
Environ Int. 2018 Feb;111:191-199. doi: 10.1016/j.envint.2017.12.002. Epub 2017 Dec 20.
6
Endocrine Disruptors Leading to Obesity and Related Diseases.
Int J Environ Res Public Health. 2017 Oct 24;14(10):1282. doi: 10.3390/ijerph14101282.
8
PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.
Toxicology. 2017 Jul 15;387:95-107. doi: 10.1016/j.tox.2017.05.013. Epub 2017 May 27.
9
Endocrine Disruptors and Obesity.
Curr Obes Rep. 2017 Mar;6(1):18-27. doi: 10.1007/s13679-017-0240-4.
10
Persistent organic pollutants alter DNA methylation during human adipocyte differentiation.
Toxicol In Vitro. 2017 Apr;40:79-87. doi: 10.1016/j.tiv.2016.12.011. Epub 2016 Dec 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验